ExxonMobil Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

ExxonMobil Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$6.33M	Sell	38,868 -1,345	-3%	-$220K	0.18%	131
2017 Q4	$6.03M	Sell	40,213 -5,828	-13%	-$863K	0.17%	142
2017 Q3	$7M	Sell	46,041 -1,780	-4%	-$268K	0.18%	136
2017 Q2	$6.16M	Sell	47,821 -7,348	-13%	-$885K	0.15%	160
2017 Q1	$6.03M	Sell	55,169 -2,242	-4%	-$197K	0.13%	183
2016 Q4	$4.23M	Sell	57,411 -5,856	-9%	-$476K	0.09%	248
2016 Q3	$5.52M	Sell	63,267 -760	-1%	-$71.8K	0.12%	216
2016 Q2	$5.51M	Buy	64,027 +4,037	+7%	+$349K	0.12%	211
2016 Q1	$4.77M	Buy	59,990 +4,915	+9%	+$445K	0.11%	221
2015 Q4	$6.93M	Sell	55,075 -1,088	-2%	-$131K	0.17%	138
2015 Q3	$5.85M	Buy	56,163 +2,051	+4%	+$264K	0.15%	161
2015 Q2	$6.68M	Sell	54,112 -4,106	-7%	-$517K	0.16%	150
2015 Q1	$6.87M	Buy	58,218 +1,513	+3%	+$181K	0.16%	164
2014 Q4	$6.74M	Sell	56,705 -1,635	-3%	-$184K	0.16%	158
2014 Q3	$6.55M	Sell	58,340 -1,753	-3%	-$167K	0.15%	160
2014 Q2	$5.69M	Sell	60,093 -1,654	-3%	-$116K	0.13%	195
2014 Q1	$4.37M	Buy	61,747 +898	+1%	+$71.1K	0.1%	243
2013 Q4	$4.52M	Sell	60,849 -1,046	-2%	-$72.8K	0.11%	222
2013 Q3	$4.69M	Buy	+61,895	New	+$4.93M	0.12%	208

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

ExxonMobil Investment Management's VRTX Position: Q1 2018 in Review

ExxonMobil Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 3.3% in Q1 2018, selling an estimated $220K and leaving 38,868 shares worth $6.33M. The position accounts for 0.18% of the portfolio, ranked #131.

ExxonMobil Investment Management first reported a position in VRTX in Q3 2013 and has held it in 19 quarters since. The position peaked at $7M in Q3 2017. 681 funds tracked by Wall St. Rank hold VRTX as of Q1 2018.

ExxonMobil Investment Management held 38,868 shares of Vertex Pharmaceuticals worth $6.33M as of Q1 2018.
ExxonMobil Investment Management sold 1,345 Vertex Pharmaceuticals shares in Q1 2018, an estimated $220K.
Vertex Pharmaceuticals made up 0.18% of ExxonMobil Investment Management's portfolio in Q1 2018, its #131 holding.
ExxonMobil Investment Management first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 19 quarters since.
ExxonMobil Investment Management's Vertex Pharmaceuticals position peaked at $7M in Q3 2017.
681 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2018.

Based on ExxonMobil Investment Management's 13F filing for Q1 2018, filed 12 Apr 2018.